Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases

Elife. 2022 Aug 3:11:e76223. doi: 10.7554/eLife.76223.

Abstract

IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity.

Keywords: ADAMTS13; Fc-FcγR interaction; IgG4; autoantibody; desmoglein 1; human; immunology; inflammation; mouse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantibodies
  • Desmoglein 1
  • Humans
  • Immunoglobulin G*
  • Mice
  • Pemphigus*
  • Receptors, IgG
  • Virulence

Substances

  • Autoantibodies
  • Desmoglein 1
  • Immunoglobulin G
  • Receptors, IgG

Grants and funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.